Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
Greil, Richard, Obrtlíková, Petra, Smolej, Lukáš, Kozák, Tomáš, Steurer, Michael, Andel, Johannes, Burgstaller, Sonja, Mikušková, Eva, Gercheva, Liana, Nösslinger, Thomas, Papajík, Tomáš, Ladická, MirVolume:
3
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/s2352-3026(16)30045-x
Date:
July, 2016
File:
PDF, 670 KB
english, 2016